Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...
In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the ...
Fondazione Telethon ETS' Waskyra has become the first gene therapy in the US for patients with Wiskott-Aldrich syndrome (WAS) ...
Epithelial ovarian cancer (EOC) is an aggressive malignancy with limited therapeutic options. Poly(ADP-ribose) polymerase ...
Bangladesh’s mobile market is at a turning point. The government is rolling out the National Equipment Identity Register ...
Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced that the first patient has been dosed in its Phase 1 ...
The day before Infantino gave Trump his Peace Prize, the US government published a new National Security Strategy document ...
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...
Purple Innovation, Inc. ("Purple") , the inventor of the GelFlex Grid and a leader in sleep innovation, today announced results from two independent validation studies conducted by SleepScore Labs, ...
Subsense announced that it added $10 million in new capital to support its nanoparticle-based brain-computer interface (BCI) platform.
This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback